China Biotech Services Holdings Ltd. is a company specializing in comprehensive biotechnology services and products. The company's primary function is to deliver precision medical diagnostic services, which play a crucial role in modern healthcare by enabling early and accurate detection of diseases. This is primarily conducted through its advanced laboratory and testing facilities, which utilize cutting-edge technology to perform a range of diagnostic tests. A significant portion of China Biotech Services’ operations focus on polymerase chain reaction (PCR) technology and related services, which are essential in areas such as infectious disease control, genetic disease screening, and various other clinical diagnostic applications. Operating predominantly in Hong Kong, the company impacts sectors like public health, pharmaceuticals, and life sciences by providing pivotal resources for disease management and research. Its role in the financial market revolves around its contributions to healthcare innovation and its potential in catering to growing demands for precise diagnostic solutions, thereby addressing pivotal needs in a rapidly evolving global health landscape.